Cancer deaths among Black men and women in the United States have declined during the past decade in the United States, a new ...

Taxpayers spent $74.5 million to help develop the prostate cancer-fighting drug Xtandi, but its sky-high sticker price is limiting access to patients and siphoning money away from Medicaid, according ...

Black men experienced the most significant relative decline in cancer deaths at nearly every age, compared to Black women and ...

An analysis of prostate cancer trends in California revealed an unexpected spike in distant-stage disease cases between 2011 and 2021.Meanwhile, prostate cancer mortality — which had been on the ...

Further assessment is needed to understand if these treatment recommendations were eventually adopted and if adoption leads to better outcomes,” researchers wrote.

A new report shows while cancer death rates among Black people are declining, they remain higher than other racial and ethnic ...

The company, now based in North Beach, has lost more than $2 billion over 29 years. Its only approved drug, called roxadustat ...

Black individuals had a 2-fold risk of cancer death related to prostate, myeloma, and stomach cancers compared with White ...

The American Cancer Society (ACS) has released Cancer Statistics for African American and Black People, 2025. According to the report, the cancer mortality rate declined from 1991 to 2022 by 49% and ...

A high omega-3, low omega-6 diet with fish oil led to a significant reduction in a biomarker for prostate cancer progression ...

The American Cancer Society (ACS) today released Cancer Statistics for African American and Black People, 2025. According to ...

Investigators report that estradiol works as well as luteinizing hormone–releasing hormone agonists for testosterone suppression and have a much better side-effect profile.